Skip to main content

Table 3 AUC0–12 change from baseline

From: The TRIFLOW study: a randomised, cross-over study evaluating the effects of extrafine beclometasone/formoterol/glycopyrronium on gas trapping in COPD

Parameter BDP/F/G BDP/F
AUC0–12 mean change p value AUC0–12 mean change p value
FEV1 (mls) 320
(257, 384)
 < 0.0001 227
(163, 290)
 < 0.0001
FVC (mls) 524
(420, 627)
 < 0.0001 351
(248, 455)
 < 0.0001
FEF25–75% (L/sec) 0.112
(0.080, 0.144)
 < 0.0001 0.082
(0.050, 0.113)
 < 0.0001
sGaw (L/s/kPa/L) 0.310
(0.259, 0.362)
 < 0.0001 0.224
(0.172, 0.275)
 < 0.0001
Raw (kPa/L/s)  − 0.298
(− 0.369, − 0.226)
 < 0.0001  − 0.242
(− 0.313, − 0.170)
 < 0.0001
RV (mls)  − 678
(− 847, − 509)
 < 0.0001  − 558
(− 727, − 389)
 < 0.0001
IC (mls) 328
(219, 438)
 < 0.0001 289
(180, 399)
 < 0.0001
FRC (mls)  − 468
(− 612, − 323)
 < 0.0001  − 426
(− 571, − 282)
 < 0.0001
TLC (mls)  − 136
(− 243, − 28)
0.0144  − 132
(− 239, − 24)
0.0174
R5–R20 (kPa/L/s)  − 0.165
(− 0.198, − 0.132)
 < 0.0001  − 0.117
(− 0.150, − 0.084)
 < 0.0001
X5 (kPa/L/s) 0.208
(0.169, 0.248)
 < 0.0001 0.159
(0.120, 0.198)
 < 0.0001
∆X5 (kPa/L/s)  − 0.207
(− 0.262, − 0.152)
 < 0.0001  − 0.140
(− 0.195, − 0.085)
 < 0.0001
Fres (1/s)  − 8.235
(− 10.108, − 6.363)
 < 0.0001  − 5.600
(− 7.472, − 3.727)
 < 0.0001
AX (kPa/L)  − 2.991
(− 3.614, − 2.368)
 < 0.0001  − 2.228
(− 2.851, − 1.604)
 < 0.0001
  1. Data = mean (95% CI) change in day 5 AUC0– 12 from pre-randomisation baseline visit AUC0–12. All AUC0–12 values (day 5 and baseline) are relative to the pre-dose value at baseline